Collegium Pharma (COLL) Tops Q1 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Collegium Reports Record Quarterly Revenue of $87.7 Million
May 6, 2021 4:01 PM EDTNet Income of $15.7 Million and Adjusted EBITDA of $45.3 Million in the First Quarter of 2021
Nucynta® Franchise and Adjusted EBITDA 2021 Guidance Range Raised
Colleen Tupper Appointed as Next CFO;Â Paul Brannelly will be Leaving the Company to Pursue Other Opportunities
Conference Call Scheduled for Today at 4:30 p.m. ET
STOUGHTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) --... More
